{
  "slug": "severe-maternal-morbidity-childbirth",
  "question": "What are the odds of a life-threatening complication during childbirth?",
  "quick_answer": "Roughly 1 in 61 US deliveries meets the definition of severe maternal morbidity (SMM), a broad near-miss category (about 163 per 10,000). Its single most common component is blood transfusion, which is sometimes precautionary; the stricter, unambiguously life-threatening subset — massive hemorrhage, eclampsia, sepsis, ICU admission — is closer to 1 in 125. Both are far more common than maternal death, which they rarely become. People anchor on the rare death and underrate the near-miss, and pre-existing conditions can multiply the risk several-fold.\n",
  "category": "kids",
  "tags": [
    "pregnancy"
  ],
  "no_reliable_estimate": false,
  "perceived": {
    "description": "Public conversation about childbirth risk in high-income countries fixates on two poles: the reassuring fact that dying in childbirth is now rare, and the alarming individual stories that periodically go viral. What sits between them — the near-miss, where a delivery becomes genuinely life-threatening but the woman survives — is largely invisible. Clinicians track it as \"severe maternal morbidity\" (SMM), a defined set of unexpected outcomes of labor and delivery with serious short- or long-term health consequences, from hemorrhage requiring massive transfusion to eclampsia, sepsis, acute renal failure, and ICU admission. Because it does not usually end in death and rarely makes the news, most people substantially underestimate how often a birth crosses into that territory, and how much a pre-existing condition can raise the odds.\n",
    "rough_estimate": "Most people know maternal death is rare in the US but have no sense of the near-miss rate, which is more than 20 times higher",
    "kind": "intuition"
  },
  "native": {
    "display": "~163 in 10,000 (about 1 in 61) US delivery hospitalizations",
    "numerator": 163,
    "denominator": 10000,
    "unit": "per delivery",
    "population": "US delivery hospitalizations"
  },
  "normalized": {
    "lifetime_us_adult": 0.0163,
    "display": "~1 in 61 per US delivery (severe maternal morbidity)",
    "log_value": -1.79,
    "assumptions": "Point estimate anchored to the national unadjusted prevalence of any severe maternal morbidity, 163.3 per 10,000 delivery discharges averaged over 2008-2021 (Fink et al., JAMA Network Open 2023), which rose to 206.1 per 10,000 (~2.1%) by 2021. The figure that includes blood transfusion (the single most common SMM indicator) runs ~135-206 per 10,000 depending on year; excluding transfusion, the stricter \"severe\" subset was 79.7 per 10,000 in 2019 (~0.8%; Hirai et al., JAMA Network Open 2022). The uncertainty band spans that definitional range (0.008-0.021). This is a per-delivery figure. Because US women who give birth average roughly 1.9 deliveries, the cumulative per-woman probability of at least one SMM event is higher, on the order of 3%.\n",
    "uncertainty": {
      "low": 0.008,
      "high": 0.021
    },
    "scope": "activity_specific_lifetime"
  },
  "sources": [
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10288331/",
      "title": "Trends in Maternal Mortality and Severe Maternal Morbidity During Delivery-Related Hospitalizations in the United States, 2008 to 2021",
      "publisher": "JAMA Network Open (Fink et al. 2023)",
      "source_type": "peer_reviewed",
      "statistic": "Unadjusted prevalence of any SMM was 163.3 per 10,000 discharges over 2008-2021, rising to 206.1 per 10,000 in 2021 from 135.2 per 10,000 in 2008",
      "excerpt": "\"The unadjusted prevalence of any SMM was estimated to be 163.3 per 10 000 discharges for the overall sample from 2008 to 2021, with higher prevalence observed in 2021 (206.1 per 10 000 discharges) compared with 2008 (135.2 per 10 000 discharges).\"\n",
      "source_date": "2023-06-16",
      "source_accessed": "2026-07-29",
      "calculation_notes": "163.3 per 10,000 = 1.63%, i.e. ~1 in 61 deliveries, the headline point estimate. This is \"any SMM\" and includes blood transfusion, the most common of the CDC's 21 indicators. The rise to 206.1 per 10,000 (~1 in 49) by 2021 sets the top of the uncertainty band. Death is a small fraction of this: SMM is defined as a near-miss, an unexpected serious outcome the woman generally survives.\n",
      "independence_note": "National discharge-data trend study; uses a definition inclusive of transfusion, complementing the transfusion-excluded estimate below.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9335134/",
      "title": "Trends in Severe Maternal Morbidity in the US Across the Transition to ICD-10-CM/PCS From 2012-2019",
      "publisher": "JAMA Network Open (Hirai et al. 2022)",
      "source_type": "peer_reviewed",
      "statistic": "National SMM rate excluding blood transfusion rose from 69.5 to 79.7 per 10,000 delivery hospitalizations between 2012 and 2019",
      "excerpt": "\"SMM rates increased from 69.5 to 79.7 per 10 000 delivery hospitalizations\" (excluding blood transfusion) between 2012 and 2019.\n",
      "source_date": "2022-07-01",
      "source_accessed": "2026-07-29",
      "calculation_notes": "79.7 per 10,000 = ~0.8%, the stricter transfusion-excluded rate and the floor of the uncertainty band. The gap between this and the 163/10,000 \"any SMM\" figure is almost entirely blood transfusion, which is why the entry brackets both rather than picking one — the honest per-delivery risk of a life-threatening event depends heavily on where transfusion is placed.\n",
      "independence_note": "Same data infrastructure family but a distinct, transfusion-excluded case definition; used to bound the estimate from below.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11775729/",
      "title": "Severe Maternal Morbidity Associated With Chronic Hypertension, Preeclampsia, and Gestational Hypertension",
      "publisher": "JAMA Network Open (Gunderson et al. 2025)",
      "source_type": "peer_reviewed",
      "statistic": "Adjusted relative risk of SMM was 5.12 for preeclampsia without chronic hypertension, 4.97 for chronic hypertension with superimposed preeclampsia, and 1.78 for gestational hypertension, vs no hypertensive disorder",
      "excerpt": "\"aRR, 4.97 [95% CI, 4.46-5.54]\" (chronic hypertension with superimposed preeclampsia); \"aRR, 5.12 [95% CI, 4.79-5.48]\" (preeclampsia without chronic hypertension); \"aRR, 1.78 [95% CI 1.60-1.99]\" (gestational hypertension).\n",
      "source_date": "2025-01-28",
      "source_accessed": "2026-07-29",
      "calculation_notes": "Grounds the hypertensive-disorder multiplier. Preeclampsia (with or without chronic hypertension) raises SMM roughly fivefold; gestational hypertension without proteinuria, ~1.8-fold. Cohort of 263,518 pregnancies in an integrated California health system, 2009-2019.\n",
      "independence_note": "Integrated-health-system cohort with individual clinical data, independent of the national discharge-trend studies above.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7236974/",
      "title": "Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy",
      "publisher": "PLoS Medicine (Davidson et al. 2020)",
      "source_type": "peer_reviewed",
      "statistic": "Adjusted relative risk of severe maternal morbidity or death was 2.84 for preconception A1c >6.4% and 1.31 for A1c 5.8-6.4%, vs A1c <5.8%",
      "excerpt": "\"The adjusted relative risk of severe maternal morbidity or death was 1.31 (95% CI 1.06-1.62) in those with a preconception A1c of 5.8%-6.4%, and 2.84 (95% CI 2.31-3.49) at an A1c >6.4%, each relative to an A1c <5.8%.\"\n",
      "source_date": "2020-05-19",
      "source_accessed": "2026-07-29",
      "calculation_notes": "Grounds the diabetes multiplier. Poorly controlled pre-existing (pregestational) diabetes, indexed by elevated preconception A1c, raises SMM-or-death roughly 2.8-fold; even mildly elevated A1c raises it ~1.3-fold. Population-based cohort.\n",
      "independence_note": "Preconception A1c cohort; distinct exposure and outcome linkage from the sources above.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Preeclampsia (per pregnancy, US)",
      "lifetime_us_adult": 0.05
    },
    {
      "label": "Gestational diabetes (per pregnancy, US)",
      "lifetime_us_adult": 0.079
    },
    {
      "label": "Serious complications from a C-section (per woman)",
      "lifetime_us_adult": 0.034
    },
    {
      "label": "Maternal death (lifetime, global)",
      "lifetime_us_adult": 0.003676
    }
  ],
  "regional_breakdown": [
    {
      "region": "US (any SMM, including blood transfusion)",
      "probability": 0.0163,
      "notes": "National average 2008-2021 (163.3/10,000). Includes transfusion, the most common indicator. This is the headline point estimate."
    },
    {
      "region": "US (2021, any SMM)",
      "probability": 0.0206,
      "notes": "The most recent year in Fink et al. 2023 (206.1/10,000, ~1 in 49). SMM has risen steadily, tracking rising maternal age, BMI, and chronic conditions entering pregnancy."
    },
    {
      "region": "US (excluding blood transfusion)",
      "probability": 0.008,
      "notes": "The stricter subset (79.7/10,000 in 2019). Removing transfusion — often a precautionary rather than life-saving intervention — roughly halves the rate."
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "Preeclampsia in this pregnancy",
      "multiplier": 5,
      "notes": "Gunderson et al. (JAMA Network Open 2025): aRR ~5.1 for preeclampsia, ~5.0 for chronic hypertension with superimposed preeclampsia, vs no hypertensive disorder."
    },
    {
      "factor": "Prior severe maternal morbidity",
      "multiplier": 3,
      "notes": "US population-based recurrence cohorts (e.g. the California linked delivery-records analysis 'Recurrence of Severe Maternal Morbidity') report ~3-fold higher risk of SMM in a subsequent birth after SMM in the first, ranging higher for specific subtypes (e.g. cardiac)."
    },
    {
      "factor": "Poorly controlled pre-existing diabetes (A1c >6.4%)",
      "multiplier": 2.8,
      "notes": "Davidson et al. (PLoS Medicine 2020): aRR 2.84 for SMM or death at preconception A1c >6.4% vs <5.8%."
    },
    {
      "factor": "Maternal age 40+",
      "multiplier": 1.6,
      "notes": "Lisonkova et al. (PLOS Medicine 2017): AOR ~1.6 for SMM at 40-44 and ~2.0 at 45-49 vs 25-29, rising to ~5.2 at 50+."
    },
    {
      "factor": "Class III obesity (BMI ≥ 40)",
      "multiplier": 1.3,
      "notes": "SMM-specific adjusted OR ~1.34 for class III obesity (BMI ≥40), rising to ~1.99 for super obesity, vs normal/overweight women, in a delivery-hospitalization study of severe maternal morbidity by obesity class (n=570,997 births). Dose-dependent with obesity class."
    }
  ],
  "short_label": "Life-threatening birth (US)",
  "myth_framing": "underrated",
  "outcome_severity": "serious_harm",
  "exposure_pattern": "acute",
  "outcome_type": "recoverable_injury",
  "valence": "negative",
  "caveats": "Two definitional points determine the number. First, \"severe maternal morbidity\" is a near-miss category, not death: it captures unexpected serious outcomes of labor and delivery — hemorrhage needing massive transfusion, eclampsia, sepsis, acute renal or cardiac failure, ICU admission — that the woman almost always survives. US maternal death is roughly 20-30 per 100,000 births, more than an order of magnitude rarer than SMM. Second, the single most common SMM indicator is blood transfusion, which is sometimes precautionary rather than strictly life-saving. Including it, the rate is ~163 per 10,000 (the figure used here); excluding it, the stricter subset is ~80 per 10,000. Both are cited; the honest per-delivery answer depends on that choice, which is why the uncertainty band spans it.\nThe rate has been rising in the US (from ~135 to ~206 per 10,000 between 2008 and 2021) and is markedly unequal: non-Hispanic Black women experience SMM at roughly roughly twice the rate of white women, a disparity only partly explained by differences in chronic conditions. The multipliers listed are not additive and not independent — a woman who is 40, has class III obesity, and develops preeclampsia does not simply multiply them out. They indicate direction and rough magnitude, not a personal total. Anemia entering delivery is a further real contributor to hemorrhage-related SMM but is harder to pin to a single multiplier and is omitted from the list rather than estimated. These figures are for high-income (US) settings; in low-resource settings both the SMM rate and the chance it progresses to death are substantially higher.\n",
  "quality_score": {
    "d1": 4,
    "d2": 5,
    "d3": 5,
    "d4": 5,
    "d5": 5,
    "d6": 5,
    "d7": 5,
    "d8": 5,
    "avg": 4.88,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-07-29",
    "methodology_version": "1.0"
  },
  "reviewer": "8d-eval-2026-07-29",
  "last_reviewed": "2026-07-29",
  "reviewed": true,
  "generated_at": "2026-07-29",
  "image": {
    "alt": "A single heartbeat line on a monitor that dips sharply then steadies, drawn in muted tones, flat vector illustration."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/severe-maternal-morbidity-childbirth"
}